Table 4b.
110 dB SPL noise exposure: Enriched pathways
Term | Count | Percentage | P |
---|---|---|---|
MAPK signaling | 13 | 0.6 | 2.4E-5 |
Type II diabetes mellitus | 4 | 0.2 | 1.6E-2 |
Calcium signaling | 7 | 0.3 | 1.8E-2 |
B cell receptor signaling | 4 | 0.2 | 5.7E-2 |
Primary immunodeficiency | 3 | 0.1 | 5.9E-2 |
Fc epsilon RI signaling | 4 | 0.2 | 6.1E-2 |
Wnt signaling | 5 | 0.2 | 8.0E-2 |
Fc gamma R-mediated phagocytosis | 4 | 0.2 | 9.2E-2 |